Exabis Library
Welcome to the e-CCO Library!
DOP21: Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP21: Role of P2X7 in intestinal fibrosis and inflammasome activation: Relevance in Crohn´s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP21: Time to first treatment with biologic agents for Ulcerative Colitis and Crohn’s Disease across four Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP21: Time to first treatment with biologic agents for Ulcerative Colitis and Crohn’s Disease across four Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP22 Certification of integral care IBD Units: Evaluation of a certification program (CUE)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP22: Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP22: Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids.
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP23 Endoscopic evaluation at 1 month after ileocolic resection for Crohn’s disease predicts postoperative recurrence and is safe
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP23: Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases – A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1